Company intelligence / Profile preview

Azidus Laboratories Limited

Chennai, Tamil Nadu, Indiaazidus.com ↗

Ownership: Private
Employees: ~60
Development stage: Phase 2

Overview

Azidus conducts bioequivalence (BA/BE) studies, clinical trials, and offers regulatory submission services. Their clinical facility includes 480 beds and 13 ICU beds in India, and 60 beds with 2 ICU beds in Ghana. They have been approved by various global drug regulatory agencies including USFDA, ANVISA Brazil, DCGI, MOH-Turkey, and others[2][5][7].

Industry: Contract Research Organization

Drug pipeline

1 asset

NestaCell

Phase 1

Indications: Huntington's disease

Beyond the preview

Go deeper on Azidus Laboratories Limited.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Azidus Laboratories Limited.

Explore the full profile